Grant: Engage Grants Program
Institut national de la recherche scientifique
$25,000.00
Evaluation of the cytotoxic and growth inhibitory effects and synergism of natural plant-derived mixtures in prostate cancer cells.
FY 2015-16
Summary
The objective of this proposal is to determine the potential anticancer actions of six natural plant-derived
extracts by determining their ability to kill prostate cancer cells or inhibit their growth. Prostate cancer is an
important burden on society as it is the most frequent cancer diagnosed in men and the second leading cause of
cancer-related death of the aging male. Prostate cancer is usually initially androgen-dependent and treatable
with antiandrogen therapy. However, often prostate cancer progresses to an androgen-independent state that is
drug-resistant and poorly treatable, resulting in metastases and death of the patient. The frequency of prostate
cancer is strongly influenced by nutrition, with a diet high in plant-derived foods acting protectively. The long
latency period in the development of prostate tumors makes this disease particularly suitable for targeting by
nutritional supplements, such as natural plant extracts. We propose to determine the ability of six plant extracts
to kill prostate cancer cells with properties reflecting various stages of the disease, including early-stage
androgen-dependent and late-stage androgen-independent tumor cells. The plant extracts will be supplied by
our collaborating company Idunn Technologies. The cellular mechanisms of cell death will be investigated to
determine exactly how the plant extracts kill the cells. In addition, various mixtures of natural plant-derived
extracts will be tested to determine potential synergistic effects on prostate cancer cell death. If it is found that
different plant extracts kill prostate cancer cells via different cell death pathways, it is possible that a combined
exposure to two or more extracts may result in greater than additive effects; this approach may also prevent
tumor cells from gaining resistance against on single treatment. The findings of this proposal will provide
essential information on the potential for certain plant extracts or mixtures of these extracts to act as effective
chemopreventive or chemotherapeutic agents, particularly in the fight against drug-resistant prostate cancer.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
484612-2015
Name nom
Sanderson, Thomas
Department département
INRS-Institut Armand-Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
1
Nb partie
1
Application title
Evaluation of the cytotoxic and growth inhibitory effects and synergism of natural plant-derived mixtures in prostate cancer cells.
Keyword
NSERC
Application summary
The objective of this proposal is to determine the potential anticancer actions of six natural plant-derived
extracts by determining their ability to kill prostate cancer cells or inhibit their growth. Prostate cancer is an
important burden on society as it is the most frequent cancer diagnosed in men and the second leading cause of
cancer-related death of the aging male. Prostate cancer is usually initially androgen-dependent and treatable
with antiandrogen therapy. However, often prostate cancer progresses to an androgen-independent state that is
drug-resistant and poorly treatable, resulting in metastases and death of the patient. The frequency of prostate
cancer is strongly influenced by nutrition, with a diet high in plant-derived foods acting protectively. The long
latency period in the development of prostate tumors makes this disease particularly suitable for targeting by
nutritional supplements, such as natural plant extracts. We propose to determine the ability of six plant extracts
to kill prostate cancer cells with properties reflecting various stages of the disease, including early-stage
androgen-dependent and late-stage androgen-independent tumor cells. The plant extracts will be supplied by
our collaborating company Idunn Technologies. The cellular mechanisms of cell death will be investigated to
determine exactly how the plant extracts kill the cells. In addition, various mixtures of natural plant-derived
extracts will be tested to determine potential synergistic effects on prostate cancer cell death. If it is found that
different plant extracts kill prostate cancer cells via different cell death pathways, it is possible that a combined
exposure to two or more extracts may result in greater than additive effects; this approach may also prevent
tumor cells from gaining resistance against on single treatment. The findings of this proposal will provide
essential information on the potential for certain plant extracts or mixtures of these extracts to act as effective
chemopreventive or chemotherapeutic agents, particularly in the fight against drug-resistant prostate cancer.